Evaluation of Intraperitoneal [<sup>18</sup>F]-FDOPA Administration for Micro-PET Imaging in Mice and Assessment of the Effect of Subchronic Ketamine Dosing on Dopamine Synthesis Capacity.

Mol Imaging · 2022 · PMC9881672 · PMID 36721730

Europe PMC DOI

hedged sentence

0.0840

closest p · 1.7× alpha

0.0840

boldest claim

The sentences

did not reach statistical significancep = 0.084so close (0.05 < p ≤ 0.1)

injection ( Figure 1(a) ), but this did not reach statistical significance (i.v.: 88.8 ± 11.7 min; i.p.: 95.4 ± 14.6 min; p = 0.084, t = 1.77, unpaired two-tailed t -test).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Evaluation of Intraperitoneal [&lt;sup&gt;18&lt;/sup&gt;F]-FDOPA Administration for Micro-PET Imaging in Mice and Assessment of the Effect of Subchronic Ketamine Dosing on Dopamine Synthesis Capacity.

The sentences

Evaluation of Intraperitoneal [<sup>18</sup>F]-FDOPA Administration for Micro-PET Imaging in Mice and Assessment of the Effect of Subchronic Ketamine Dosing on Dopamine Synthesis Capacity.